Back
Apellis Pharmaceuticals Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Buy
53
APLS
Apellis Pharmaceuticals
Last Price:
$33.26
Seasonality Move:
14.66%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
The current trend is moderately bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.56 | Sell |
| 20-day SMA: | 33.63 | Sell |
| 50-day SMA: | 30.14 | Buy |
| 200-day SMA: | 39.25 | Sell |
| 8-day EMA: | 33.57 | Sell |
| 20-day EMA: | 32.94 | Buy |
| 50-day EMA: | 31.96 | Buy |
| 200-day EMA: | 38.48 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.92 | Buy |
| Relative Strength Index (14 RSI): | 53.6 | Buy |
| Chaikin Money Flow: | -2104619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.64 - 35.1) | Buy |
| Bollinger Bands (100): | (28.23 - 37.21) | Buy |
Apellis Pharmaceuticals Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 33.18 while APLS 8-day simple moving average is 33.56, which is a Sell signal.
-
The stock price of APLS is 33.18 while Apellis Pharmaceuticals 20-day SMA is 33.63, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 30.14 while APLS share price is 33.18, making it a Buy technically.
-
APLS stock price is 33.18 and Apellis Pharmaceuticals 200-day simple moving average is 39.25, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Buy
53
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a BuyThe current Apellis Pharmaceuticals [APLS] share price is $33.18. The Score for APLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
4.1B
Price in USD:
33.18
Share Volume:
3.6M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
24.34
Buy
53
Apellis Pharmaceuticals (APLS)
is a Buy
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 33.18 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is not overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 33.18 while APLS 8-day exponential moving average is 33.57, which is a Sell signal.
-
The stock price of APLS is 33.18 while Apellis Pharmaceuticals 20-day EMA is 32.94, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day exponential moving average is 31.96 while APLS share price is 33.18, making it a Buy technically.
-
APLS stock price is 33.18 and Apellis Pharmaceuticals 200-day simple moving average is 38.48, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.82 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is 0.92, suggesting Apellis Pharmaceuticals is a Buy
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 53.6, which suggest Apellis Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (29.64 - 35.1), which suggest Apellis Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (28.23 - 37.21), which suggest Apellis Pharmaceuticals is a Buy
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.